[High altitude simulation test for patients with lung disease]

Mengarelli C, Bardach A, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Ciapponi A.
Record ID 32018001433
Original Title: Prueba de simulación de altura en pacientes con enfermedad pulmonar
Authors' recommendations: CONCLUSIONS Very low-quality evidence does not allow determining the usefulness of the high altitude simulation test in deciding the need for supplemental oxygen in patients with stable moderate-severe chronic obstructive pulmonary disease, in order to assess air travel contraindications. No studies have been found comparing the high altitude simulation test with other methods that would allow assessing air travel contraindications in patients with lung disease or the need for supplemental oxygen. The clinical practice guidelines mentioning the high altitude simulation test recommend that patients with an oxygen saturation of less than 92% should use supplemental oxygen therapy during flights and that those with an 92-95% oxygen saturation should perform the high altitude simulation test to determine supplemental oxygen indication. The Latin American health sponsors assessed do not cover or mention this technology. Only a few health sponsors from high-income countries do cover it. No economic assessments have been found in Argentina.
Project Status: Completed
Year Published: 2018
URL for published report: https://www.iecs.org.ar/home-ets/
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Argentina
MeSH Terms
  • Pulmonary Disease, Chronic Obstructive
  • Altitude
  • Hypoxia
  • Aerospace Medicine
  • Air Travel
  • Travel Medicine
  • Oxygen
Organisation Name: Institute for Clinical Effectiveness and Health Policy
Contact Address: Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name: info@iecs.org.ar
Contact Email: info@iecs.org.ar
Copyright: Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.